Best Use of the Tyrosine Kinase Inhibitors in Progressive Differentiated Thyroid Cancer: Discussion.

Discussion. Clin Adv Hematol Oncol. 2016 May;14 Suppl 9(5):12-13 Authors: Tuttle RM, Brose MS PMID: 27168343 [PubMed - as supplied by publisher]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research